drugset / Trial / NCT00584844

Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

NCT00584844 ↗

NaSingle-groupOpen-labelPrevention

Summary

This study is designed to determine the safety and immunogenicity of a Live Francisella tularensis Vaccine

Timeline

Start
2004-10
Primary completion
2009-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Live F tularensis Vaccine Vaccine 0.0025 ml Other

Indications